Zhongshan Hospital Fudan University
Shanghai, Shanghai Municipality, 200032, China
Location status: Recruiting
NCT Number: NCT05539105
This study is designed as a prospective, real world registry study that compare the safety and efficacy of the different construction methods after radical proximal gastrectomy.
Interested in participating?
Request Info18 year–80 year
All sexes
Observational
Shanghai, Shanghai Municipality, 200032, China
Location status: Recruiting
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Double tract reconstruction would be applied after radical proximal gastrectomy.
Gastric conduit reconstructionn would be applied after radical proximal gastrectomy.
Other reconstructions except for double tract and gastric conduit reconstructions would be applied after radical proximal gastrectomy.
Time frame: 1 year
Reflux esophagitis refers to esophageal erosions and/or esophageal ulcers caused by the reflux of esophageal contents into the esophagus or above (oral mouth, throat, lungs) causing complaints of discomfort and endoscopic manifestations of esophageal mucosal defects.
Time frame: 30 days
Take the total number of patients receiving surgical treatment as the denominator, and the number of patients with intraoperative/postoperative early and late complications during any one and follow-up as the numerator to calculate the proportion;
Time frame: 12 months
Body weight(kg)would be monitored during follow-up after surgery.
Time frame: 12 months
Albumin(g/L) would be monitored during follow-up after surgery.
Time frame: 12 months
Hemoglobin(g/L) would be monitored during follow-up after surgery.
Time frame: 3 years
The time between the date of surgery as the starting point and the date of tumor recurrence as the ending point (or the date of death due to tumor cause when the exact date of tumor recurrence is not known).
When neither death nor tumor recurrence was observed at follow-up, the final date of confirmation of recurrence-free survival (final recurrence-free survival confirmation date: the last of the date of the outpatient visit or the date of the examination received) was used.
Time frame: 30 days
Taking the total number of patients receiving surgical treatment as the denominator, and observing any of the following patients as the numerator, the ratio calculated as the surgical death ratio:
Shanghai Zhongshan Hospital
Other
Acronym: STAR-PG01
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05514769
Deglutition Disorders, Digestive System Diseases
Nanchong, Sichuan, China
View Trial DetailsNCT06477562
Digestive System Diseases, Digestive System Neoplasms
Suwon, Gyeong-Gi-Do, South Korea
View Trial DetailsNCT06062225
Anastomosis, Digestive System Diseases
View Trial DetailsNCT06996145
Anterior Cruciate Ligament (ACL), Reconstruction
Amiens, France
View Trial Details